{
  "timestamp": "2025-09-22T23:03:29.753250",
  "validations": {
    "drug_names": {
      "metric": "drug_names",
      "precision": 0.44776119402985076,
      "recall": 0.11811023622047244,
      "f1_score": 0.18691588785046728,
      "matches": 30,
      "missing_from_pipeline": [
        "imgn151",
        "abbv-969",
        "abbv-cls-579",
        "rg6648 / yl211",
        "ds-1103",
        "venclexta",
        "clesitamig / alps12",
        "bay 3713372",
        "jnj-2761",
        "patritumab deruxtecan\n(mk-1022)",
        "mrna-4157",
        "rg6620 / gdc-7035",
        "abbv-cls-484",
        "sail66",
        "kfa115",
        "mrna-2808",
        "pan kras",
        "asp4396",
        "tar-210 (ris/erdafitinib)",
        "valemetostat",
        "intismeran autogene (v940)",
        "abp 206",
        "denikitug (gs-1811)",
        "jnj-8177 (arx517)",
        "ifinatamab deruxtecan",
        "jnj-1900 (nbtxr3)",
        "gs-2121",
        "iov-4001",
        "amg 410",
        "sacituzumab tirumotecan\n(mk-2870)",
        "mrna-4106",
        "rezatapopt",
        "abp 234",
        "abbv-706",
        "aaa614",
        "aaa802",
        "asp3082",
        "datopotamab deruxtecan-dlnk",
        "trastuzumab emtansine",
        "sevabertinib",
        "esp359",
        "bay 3547926",
        "pivekimab sunirine (pvek)",
        "autogene cevumeran",
        "bay 2862789",
        "tar-200 (ris/gemcitabine plus cetrelimab)",
        "parp1 inhibitor (gs-0201)",
        "abemaciclib",
        "abiraterone decanoate/asp5541",
        "rg6440 / sof10",
        "fxx489 (177lu-nns309)",
        "mk-1084",
        "jnj-3413",
        "olomorasib",
        "zelenectide pevedotin (formerly bt8009)",
        "rg6468",
        "abbv-319",
        "anti-tim3 combo s95018",
        "gdc-6036",
        "abbv-525",
        "patritumab deruxtecan",
        "27t51",
        "vorasidenib + temozolomide s95032",
        "iov-2001",
        "opevesostat\n(mk-5684)",
        "rg6537, gdc-2992",
        "rgt-419b",
        "ttx-030",
        "a2b543",
        "mint91",
        "sacituzumab govitecan-hziy",
        "fra adc",
        "jnj-2638",
        "jnj-8377",
        "bay 3498264",
        "selpercatinib",
        "vvd-159642, bay 3674171",
        "vorasidenib s95032",
        "nvl-655 (neladalkib)",
        "iov-3001",
        "ds-3939",
        "bomedemstat\n(mk-3543)",
        "vvd-130850, bay 3630914",
        "mgy825",
        "giredestrant",
        "ivosidenib s95031",
        "abbv-453",
        "bay 2965501",
        "jsb462 (luxdegalutamide)",
        "[ac-225]-psma-62",
        "mrna-4359",
        "mcl1 inhibitor (gs-9716)",
        "nvl-330",
        "asp2138",
        "nectin-4 adc 1",
        "asp1002",
        "jnj-0387",
        "nezastomig (regn5678)",
        "raludotatug deruxtecan\n(mk-5909)",
        "jnj-4916",
        "abbv-514",
        "ifinatamab deruxtecan (mk-2400)",
        "imlunestrant",
        "aaa601",
        "ln-145 gen 3",
        "a2b530",
        "pi3k\u03b1 inhibitor (stx-478)",
        "regn4336",
        "codrituzumab",
        "dgk\u03b1 inhibitor (gs-9911)",
        "rg6540",
        "amg 193",
        "tarlatamab-dlle",
        "jnj-0683 (arx788)",
        "rg6411",
        "mosperafenib",
        "ivosidenib + durvalumab + gemcitabine/cisplatine s95031",
        "quizartinib",
        "rg6538",
        "raludotatug deruxtecan",
        "ds-9606",
        "talquetamab",
        "vonsetamig (regn5459)",
        "jnj-9401",
        "mat2a inhibitor s95035",
        "trastuzumab deruxtecan",
        "temab-a (abbv-400)",
        "divarasib / gdc-6036 / rg6330",
        "vepugratinib (fgfr3 selective)",
        "paluratide / luna18",
        "abbv-303",
        "iag933",
        "nezastomig (regn5678) / regn4336",
        "dzr123",
        "fianlimab",
        "zilovertamab vedotin\n(mk-2140)",
        "eci830",
        "hro761",
        "quemliclustat +/- zimberelimab (arc-8)",
        "nectin-4 adc 2",
        "ds-2243",
        "vvd-214",
        "pexidartinib",
        "bemarituzumab",
        "amg 355",
        "raf/ras inhibitor s241656",
        "jnj-5322",
        "rg6221",
        "masked il-12 (xtx301)",
        "bt5528",
        "quavonlimab + pembrolizumab\n(mk-1308a)",
        "il-2 variant (gs-4528)",
        "jnj-6420",
        "subcutaneous pembrolizumab\n(mk-3475a)",
        "lung cancer platform (velocity-lung, edge-lung)",
        "aaa603 (177lu-neob)",
        "daratumumab",
        "apalutamide",
        "rg6810",
        "rg6561",
        "teclistamab",
        "olaparib (mk-7339)",
        "belzutifan (mk-6482)",
        "aaa617",
        "teliso-v (telisotuzumab vedotin)",
        "kras g12d",
        "davutamig (regn5093)",
        "regn5668",
        "jnj-8343",
        "moxetumomab pasudotox",
        "rg6596 / zn-a-1041",
        "jnj-0631 (arx305)",
        "ibrutinib",
        "il-18bp (gs-0321)",
        "anti-cd73 combo s95024",
        "bleximenib",
        "hyaluronidase, pertuzumab, and trastuzumab",
        "mk-6070 (ds3280)",
        "asp546c/xnw27011",
        "nemtabrutinib\n(mk-1026)",
        "etentamig (abbv-383)",
        "nvl-520 (zidesamtinib)",
        "byl719",
        "linvoseltamab",
        "ciltacabtagene autoleucel",
        "budigalimab / abbv-181",
        "anti-nkg2a combo s95029",
        "xaluritamig",
        "bay 3546828",
        "rose12",
        "aaa817",
        "mrna-4203",
        "tiragolumab",
        "pembrolizumab (mk-3475)",
        "ptk7 adc",
        "amivantamab",
        "fam-trastuzumab deruxtecan-nxki",
        "vorasidenib + pembrolizumab s95032",
        "alectinib",
        "englumafusp alfa",
        "smarca2 (brm)",
        "pirtobrutinib",
        "domvanalimab + zimberelimab + chemotherapy",
        "regn10597",
        "cevostamab",
        "bay 3375968",
        "bay 3563254",
        "a2b395",
        "amg 305",
        "ubamatamab (regn4018)",
        "asp1570",
        "lifileucel/ln-144",
        "regn7075",
        "vvd-130037 aka nrf2 inh, bay 3605349",
        "lifileucel",
        "polatuzumab vedotin piiq",
        "niraparib/abiraterone",
        "odronextamab",
        "a2b694",
        "jnj-4680",
        "abbv-101",
        "rg6620",
        "ln-145-s1",
        "rg6505"
      ],
      "extra_in_pipeline": [
        "doxorubicin hydrochloride",
        "methotrexate",
        "panitumumab",
        "imatinib oral",
        "sorafenib",
        "docetaxel",
        "temsirolimus",
        "imatinib mesylate",
        "gemcitabine hydrochloride",
        "belzutifan",
        "avelumab",
        "cyclophosphamide for injection",
        "erlotinib hydrochloride",
        "fluorouracil",
        "cyclophosphamide",
        "etoposide",
        "sunitinib malate",
        "ipilimumab",
        "docetaxel anhydrous",
        "nivolumab",
        "erlotinib",
        "rituximab and hyaluronidase",
        "pembrolizumab",
        "cisplatin",
        "methotrexate sodium",
        "temsirolimus injection",
        "except",
        "carboplatin",
        "tarlatamab",
        "paclitaxel",
        "gemcitabine intravesical",
        "alectinib hydrochloride",
        "lapatinib",
        "everolimus",
        "cetuximab",
        "contracept",
        "etoposide phosphate"
      ],
      "total_gt_drugs": 254,
      "total_pipeline_drugs": 67
    },
    "company_coverage": {
      "metric": "company_coverage",
      "precision": 0.027777777777777776,
      "recall": 0.047619047619047616,
      "f1_score": 0.03508771929824561,
      "matches": 1,
      "missing_from_pipeline": [
        "abbvie",
        "astellas",
        "genentech",
        "moderna",
        "bicycle",
        "roche",
        "gilead",
        "regeneron",
        "iovance",
        "astrazeneca",
        "jnj",
        "bayer",
        "novartis",
        "pmv pharma",
        "servier",
        "a2",
        "nuvalent",
        "eli lilly",
        "daiichi",
        "merck"
      ],
      "extra_in_pipeline": [
        "emd serono, inc.",
        "bayer healthcare pharmaceuticals inc.",
        "imclone llc",
        "bristol myers squibb",
        "slate run pharmaceuticals, llc",
        "h2-pharma, llc",
        "endo usa, inc.",
        "immunogen, inc.",
        "cipla usa inc.",
        "merck & co.",
        "gland pharma limited",
        "teva pharmaceuticals, inc.",
        "astrazeneca pharmaceuticals lp",
        "dr. reddy's laboratories inc.",
        "msn laboratories private limited",
        "astellas pharma us, inc.",
        "mylan institutional llc",
        "amneal pharmaceuticals llc",
        "genmab us, inc.",
        "fresenius kabi usa, llc",
        "seagen inc.",
        "bluepoint laboratories",
        "sanofi-aventis u.s. llc",
        "abbvie inc.",
        "upsher-smith laboratories, llc",
        "sun pharmaceutical industries, inc.",
        "daiichi sankyo",
        "shorla oncology inc.,",
        "baxter healthcare corporation",
        "roche/genentech",
        "onyx pharmaceuticals, inc.",
        "hospira, inc.",
        "regeneron pharmaceuticals, inc.",
        "golden state medical supply, inc.",
        "mylan pharmaceuticals inc."
      ],
      "total_gt_companies": 21,
      "total_pipeline_companies": 36
    },
    "mechanisms": {
      "metric": "mechanisms",
      "accuracy": 0.13636363636363635,
      "exact_matches": 1,
      "partial_matches": 1,
      "mismatches": 9,
      "total_common_drugs": 11,
      "mismatch_details": [
        {
          "drug": "obinutuzumab",
          "ground_truth": "triggger B cell destruction and ADCC",
          "pipeline": "Therapeutic Protein"
        },
        {
          "drug": "inavolisib",
          "ground_truth": "inhibits PI3K",
          "pipeline": "Kinase Inhibitor"
        },
        {
          "drug": "cemiplimab",
          "ground_truth": "ICI",
          "pipeline": "Monoclonal Antibody"
        },
        {
          "drug": "rituximab",
          "ground_truth": "eliminating malignant B-cells in cancers or reducing auto-antibody producing B-cells in autoimmune diseases",
          "pipeline": "Therapeutic Protein"
        },
        {
          "drug": "bevacizumab",
          "ground_truth": "block VEGF and inhibits angiogenesis",
          "pipeline": "Therapeutic Protein"
        },
        {
          "drug": "atezolizumab",
          "ground_truth": "ICI",
          "pipeline": "Monoclonal Antibody"
        },
        {
          "drug": "mosunetuzumab",
          "ground_truth": "engage both CD20 on B cells and CD3 on T cells, activates the T cells to attack and eliminate the B cells, allowing treatment of B cell cancers such as non-Hodgkin\u2019s lymphoma.",
          "pipeline": "Monoclonal Antibody"
        },
        {
          "drug": "cobimetinib",
          "ground_truth": "RAS/RAF/MEK/ERK pathway inhibition",
          "pipeline": "Kinase Inhibitor"
        },
        {
          "drug": "vemurafenib",
          "ground_truth": "inhibits BRAF V600",
          "pipeline": "Kinase Inhibitor"
        }
      ]
    },
    "clinical_trials": {
      "metric": "clinical_trials",
      "overall_coverage": 3.275,
      "total_gt_trials": 280,
      "total_pipeline_trials": 917,
      "common_drugs_analyzed": 0,
      "coverage_analysis": []
    }
  },
  "summary": {
    "total_validations": 4,
    "overall_health": "Good",
    "key_metrics": {
      "drug_names_f1": 0.18691588785046728,
      "company_coverage_f1": 0.03508771929824561,
      "mechanisms_accuracy": 0.13636363636363635,
      "clinical_trials_coverage": 3.275
    },
    "recommendations": []
  }
}